维普期刊资源整合服务平台（V6.5）

35篇 您的检索式：作者名="Corbin AS"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Human chronic myeloid leukemia stem cells are insensitive to imatinib de- spite inhibition of BCR- ABL activity显示文摘	Corbin AS Aganval A Loriaux M	2011	J Clin Invest2011，121，1：	1
2	Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease 显示文摘	Agarwal A Bumm TG Corbin AS	2008	Blood2008，112，5：	1
3	Molecular and chromosomal mechanisms of resistance to imatinib ( STI571 ) therapy显示文摘	Hochhaus A Kreil S Corbin AS	2002	Leukemia2002，16，11：	1
4	In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Ablpositive cell lines显示文摘	Johnson K Corbin AS	2004	Blood2004，103，1：	1
5	Human chronic myeloid leukemia stem cells are insensitive to imatinJb despite inhibition of BCI-ABL &ctivity显示文摘	Corbin AS Agarwal A Loriaux M et aI	2011	The Journal of Clinic&l Investig&tion2011，121，：	1
6	Human chronic myeloidleukemia stem cells are insensitive to imatinib despite inhibition ofBCR-ABL activity显示文摘	Corbin AS Agarwal A Loriaux M	2011	J Clin Invest2011，121，1：	1
7	Characterization of routine JAK2V617Fpositive myeloproliferative disease显示文摘	Thomas GP Elsea C Corbin AS	2006	Cancer Research2006，66，11：	1
8	Molecular and chromosomal mechanisms of resistence to imatinib ( STI571 )therapy显示文摘	Hochhaus A Kreil S Corbin AS	2002	Leukemia2002，16，：	1
9	Characterization of murine JAK2V617F-positive myeloproliferative disease显示文摘	Bumm TG Elsea C Corbin AS	2006	Cancer Res2006，66，11：	1
10	Molecular and chromosomal mechanisms of resisitence to imatinib ( STI571 ) therapy 显示文摘	Hochhaus A Kreil S Corbin AS	2002	Leukemia2002，16，：	1
11	In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Abl-positive cell lines 显示文摘	Rosee PL Johnson K Corbin AS	2004	Blood2004，103，：	1
12	Molecular and chromosomal mechanisms of resistance to imatlnib( ST1571 ) therapy显示文摘	Hochhaus A Kreil S Corbin AS	2002	Leukemia2002，16，11：	1
13	Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy显示文摘	Hochhaus A Kreil S Corbin AS	2002	Leukemia2002，16，11：	1
14	Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy显示文摘	Hochhaus A Kreil S Corbin AS	2002	Leukemia2002，16，11：	1
15	Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR - ABL ac- tivity显示文摘	Corbin AS Agarwal A Loriaux M	2011	J Clin Invest2011，121，1：	1
16	Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of bcr-abl activity显示文摘	Corbin AS Agarwal A Loriaux M et at	2011	J Clin Invest2011，121，：	1
17	Characterization of murine JAK2V617F-positive myeloproliferative disease显示文摘	Bumm TG Elsea C Corbin AS	2006	Cancer Res2006，66，11：	1
18	Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity显示文摘	Corbin AS Agarwal A Loriaux M	2011	J Clin Invest2011，121，1：	1
19	Molecular and chromosomal mechanisms of resistance to imatinib (ST1571) therapy显示文摘	Hoehhaus A Kreil S Corbin AS	2002	Leukemia2002，16，11：	1
20	Molecular and chromosomal mechanisms of resistance to imatinib(STI571) therapy显示文摘	Hochhaus A Kreil S Corbin AS		0，，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示